Plant-based production of xenogenic proteins

Current Opinion in Biotechnology

Volumn 10, Issue 4, 1999, Pages 382-386

  Hood, Elizabeth E ^a   Jilka, Joseph M ^a  

^a Prodigene Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CANCER VACCINE; CHOLERA VACCINE; ENZYME; HEPATITIS B VACCINE; PROTEIN; RABIES VACCINE; VACCINE; VIRUS VACCINE;

ANTIBODY PRODUCTION; BIOTECHNOLOGY; INDUSTRY; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SYNTHESIS; SHORT SURVEY; TRANSGENIC PLANT;

EID: 0033179650     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(99)80069-X     Document Type: Article

References (25)

1. Brennan F, Bellaby T, Helliwell S, Jones T, Kamstrup S, Dalsgaard K, Flock J, Hamilton W: Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice. J Virol 1999, 73:930-938. This study demonstrates efficacy of chimeric virus particles in inducing immune responses after three different delivery formats.
2. Brennan F, Jones T, Gilleland L, Bellaby T, Xu F, North P, Thompson A, Staczek J, Lin T, JOhnson J et al.: Pseudomonas aeruginosa outermembrane protein F epitopes are highly immunogenic in mice when expressed on a plant virus. Microbiol 1999, 145:211-220.
3. Dalsgaard K, Uttenthal A, Jones T, Xu F, Merryweather A, Hamilton W, Langeveld J, Boshuizen R, Kamstrup S, Lomonossoff P et al.: Plant- derivedderived vaccine protects target animals against a viral disease. Nat Biotechnol 1997, 15:248-252.
4. Modelska A, BIetzschold B, Sleysh N, Fu Z, Steplewski K, Hooper D, Koprowski H, Yusibov V: Immunization against rabies with plant- derived antigen. Proc Natl Acad Sci USA 1998, 95:2481-2485.
5. Zeitlin L, Olmsted S, Moench T, Co M, Martinell B, Paradkar V, Russell D, Queen C, Cone R, Whaley K: A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes. Nat Biotechnol 1998, 16:1361-1364. A soybean-derived humanized monoclonal antibody protected mice from genital herpes when applied topically to the vagina.
6. Hiatt A, Cafferkey R, Bowdish K: Production of antibodies in transgenic plants. Nature 1989, 342:76-78.
7. Conrad U, Fiedler U: Compartment specific accumulation of recombinant immunoglobulins in plant cells: An essential tool for antibody production and immunomodulation of physiological functions and pathogen activity. Plant Mol Biol 1998, 38:101-109.
8. De Wilde C, De RYcke R, Beeckman T, De Neve M, Montagu MV, Engler G, Depicker: Accumulation patterns of IgG antibodies and F-ab fragments in transgenic Arabidopsis thaliana plants. Plant Cell Physiol 1998, 39:639-646.
9. Ma J, Hiatt A, Hein M, Vine N, Wang F, Stabila P, Van Dolleweerd C, Mostov K, Lehner T: Generation and assembly of secretory antibodies in plants. Science 1995, 268:716-719.
10. Potera C: Epicyte produces antibodies in plants. Gen Eng News 1999, February: 15.
11. Verch T, Yusibov V, Koprowski H: Expression and assembly of a full- lengthlength monoclonal antibody in plants using a plant virus vector. J Immunol Methods 1998, 220:69-75.
12. Hood E, Witcher D, Maddock S, Meyer T, Baszczynski C, Bailey M, Flynn P, Register J, Marshall L, Bond D et al.: Commercial production of avidin from transgenic maize: Characterization of transformant, production, processing, extraction and purification. Mol Breed 1997, 3:291-306.
13. Witcher D, Hood E, Peterson D, Bailey M, Bond D, Kusnadi A, Evangelista R, Nikolov Z, Wooge C, Mehigh R et al.: commercial production of β-glucuronidase (GUS): A model system for the production of proteins in plants. Mol Breed 1998, 4:301-312.
14. Hood E, Kusnadi A, Nikolov Z, Howard J: Molecular farming of industrial proteins from transgenic maize. In Chemicals Via Higher Plant Bioengineering. Edited by Shahidi F, Kolodziejczyk P, Whitaker J, Lopez Munguia A, Fuller G. Plenum Publishing Corp.; 1999:127-148. This chapter summarizes all aspects of production of the first two products marketed from transgenic maize - transformation, biochemistry, genetics, scale-up, processing, and purification.
15. Kusnadi A, Nikolov Z, Howard J: Production of recombinant proteins in transgenic plants: Practical considerations. Biotechnol Bioeng 1997, 56:473-484.
16. Ziegler M, Thomas S, Danna K: Accumulation of thermostable endo-1,4-β-D-glucanase in the apoplast of Arabidopsis thaliana. Mol Breed 1999, in press. A cell-wall degrading enzyme, endo-1,4-β-D-glucanase, was expressed at 25% of total soluble protein in Arabidopis. This thermophilic enzyme was not active at normal growth temperatures and did not degrade plant tissues with which it was in direct contact.
17. Liu J, Selinger B, Cheng K, Beauchemin K, MOloney M: Plant seed oil-bodies as an immobilization matrix for a recombinant xylanase from the rumen fungus Neocallimastix patriciarum. Mol Breed 1997, 3:463-470.
18. Arakawa T, Chong D, Merritt J, Langridge W: Expression of cholera toxin B subunit oligomers in transgenic potato plants. Trans Res 1997, 6:403-413.
19. Arakawa T, Chong D, Langridge W: Efficacy of a food plant-based oral cholera toxin B subunit vaccine. Nat Biotechnol 1998, 16:292-297.
20. Tacket C, Mason H, Losonsky G, Clement J, Levine M, Arntzen C: Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat Med 1998, 4:607-609.
21. Rooijen V, MOloney M: Structural requirements of oleosin domains for subcellular targeting to the oilbody. Plant Physiol 1995, 109:1353-1361.
22. Kusnadi A, Hood E, Witcher D, Howard J, Nikolov Z: Production and purification of two recombinant proteins from transgenic corn. Biotechnol Prog 1998, 14:149-155. Key issues in stability and fractionation are addressed in relation to avidin and GUS, the first two commercially sold proteins from transgenic plants.
23. Kusnadi A, Evangelista R, Hood E, Howard J, Nikolov Z: Processing of transgenic corn seed and its effect on the recovery of recombinant β-glucuronidase. Biotechnol Bioeng 1998, 60:44-52. A complete paradigm is developed for processing, extraction and purification of an enzyme from transgenic maize.
24. Mason H, Haq T, Clements J, Arntzen C: Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): Potatoes expressing a synthetic LT-B gene. Vaccine 1998, 16:1336-1343.
25. Ma K, Hikmat B, Wycoff K, Vine N, Chargelegue D, Yu L, Hein M, Lehner T: Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in human. Nat Med 1998, 4:601-606. This study describes the first human clinical trial in which a protein from a transgenic plant was effective in disease prevention. A monoclonal anti- body was applied topically to teeth and prevented colonization by Streptococcus mutans.